New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling

Blood

Volumn 113, Issue 11, 2009, Pages 2488-2497

  Martín Subero, José I ^a   Kreuz, Markus ^b   Bibikova, Marina ^c   Bentink, Stefan ^d   Ammerpohl, Ole ^a   Wickham Garcia, Eliza ^c   Rosolowski, Maciej ^b   Richter, Julia ^a   Lopez Serra, Lidia ^e   Ballestar, Esteban ^e   Berger, Hilmar ^b   Agirre, Xabier ^f   Bernd, Heinz Wolfram ^g   Calvanese, Vincenzo ^e   Cogliatti, Sergio B ^h   Drexler, Hans G ⁱ   Fan, Jian Bing ^c   Fraga, Mario F ^e   Hansmann, Martin L ^j   Hummel, Michael ^k   Klapper, Wolfram ^a   Korn, Bernhard ^l   Küppers, Ralf ^m   MacLeod, Rodericka F ⁱ   Möller, Peter ⁿ   Ott, German ^o   Pott, Christiane ^a   Prosper, Felipe ^f   Rosenwald, Andreas ^o   Schwaenen, Carsten ⁿ   Schübeler, Dirk ^p   Seifert, Marc ^m   Stürzenhofecker, Benjamin ^q   Weber, Michael ^p   Wessendorf, Swen ⁿ   Loeffler, Markus ^b   Trümper, Lorenz ^q   Stein, Harald ^k   Spang, Rainer ^d   Esteller, Manel ^e   Barker, David ^c   Hasenclever, Dirk ^b   Siebert, Reiner ^a   more..

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c ILLUMINA INC   (United States)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e Centro Nacional de Investigaciones Oncológicas   (Spain)

^f UNIVERSITY OF NAVARRA   (Spain)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^h CANTONAL HOSPITAL ST GALLEN   (Switzerland)

ⁱ LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^j UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^l GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^m UNIVERSITY OF DUISBURG ESSEN   (Germany)

ⁿ UNIVERSITY HOSPITAL ULM   (Germany)

^o UNIVERSITY OF WÜRZBURG   (Germany)

^p FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^q UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CELL MATURATION; DNA FINGERPRINTING; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; FEMALE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETICS; GENOMICS; HEMATOPOIETIC TISSUE; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; MORPHOLOGY; PRIORITY JOURNAL; STEM CELL;

EID: 64049094683     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-04-152900     Document Type: Article

References (50)

1. Esteller M. Cancer epigenomics: DNAmethyl- omes and histone-modification maps. Nat Rev Genet. 2007;8:286-298.
2. Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128:683-692.
3. Laird PW. Cancer epigenetics. Hum Mol Genet. 2005;14(Spec No 1):R65-R76.
4. Ting AH, McGarvey KM, Baylin SB. The cancer epigenome-components and functional correlates. Genes Dev. 2006;20:3215-3231.
5. Keshet I, Schlesinger Y, Farkash S, et al. Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat Genet. 2006;38: 149-153.
6. Ohm JE, Baylin SB. Stem cell chromatin patterns: an instructive mechanism for DNA hypermethyl- ation Cell Cycle. 2007;6:1040-1043.
7. Ohm JE, McGarvey KM, Yu X, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet. 2007;39:237-242.
8. Schlesinger Y, Straussman R, Keshet I, et al. Polycomb-mediated methylation on Lys27 of his- tone H3 pre-marks genes for de novo methylation in cancer. Nat Genet. 2007;39:232-236.
9. Widschwendter M, Fiegl H, Egle D, et al. Epige- netic stem cell signature in cancer. Nat Genet. 2007;39:157-158.
10. Feinberg AP, Ohlsson R, Henikoff S. The epige- netic progenitor origin of human cancer. Nat Rev Genet. 2006;7:21-33.
11. Kuppers R, Klein U, Hansmann ML, RajewskyK. Cellular origin of human B-cell lymphomas. N Engl J Med. 1999;341:1520-1529.
12. Willis TG, Dyer MJ. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood. 2000;96:808-822.
13. Leich E, Hartmann EM, BurekC, Ott G, Rosenwald A. Diagnostic and prognostic significance of gene expression profiling in lymphomas. APMIS. 2007;115:1135-1146.
14. Staudt LM, Dave S. The biology of human lym- phoid malignancies revealed by gene expression profiling. Adv Immunol. 2005;87:163-208.
15. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403: 503-511.
16. Dave SS, Fu K, Wright GW, etal. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med. 2006; 354:2431-2442.
17. Hummel M, Bentink S, Berger H, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med. 2006; 354:2419-2430.
18. Monti S, Savage KJ, Kutok JL, et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood. 2005;105: 1851-1861.
19. Montesinos-Rongen M, Brunn A, Bentink S, et al. Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell. Leukemia. 2008;22:400-405.
20. Bibikova M, Lin Z, Zhou L, et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res. 2006;16:383-393.
21. Paz MF, Fraga MF, Avila S, et al. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res. 2003;63:1114-1121.
22. Calvanese V, Horrillo A, Hmadcha A, et al. Cancer genes hypermethylated in human embryonicstem cells. PLoS ONE. 2008;3:e3294.
23. Jiang Y, Dunbar A, Gondek LP, et al. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. Blood. 2009;113:1315-1325.
24. McLendon R, Friedman A, Bigner D, et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455:1061-1068.
25. Tost J, Gut IG. DNA methylation analysis by pyro- sequencing. Nat Protoc. 2007;2:2265-2275.
26. University of Otago. Imprinted Genes and Related Effects. http://igc.otago.ac.nz/home.html. Accessed October 2007.
27. GeneImprint. Imprinted Genes: by Species. http:// www.geneimprint.com/ site/genes-by-species. Accessed October 2007.
28. Murphy SK, Jirtle RL. Imprinting evolution and the price of silence. Bioessays. 2003;25:577-588.
29. Lee TI, Jenner RG, Boyer LA, et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell. 2006;125:301-313.
30. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 2006;20:1123-1136.
31. Weber M, Hellmann I, Stadler MB, et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet. 2007;39:457-466.
32. Gentleman RC, Carey VJ, Bates DM, et al. Bio- conductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
33. Gautier L, Cope L, Bolstad BM, Irizarry RA. affy: analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20:307-315.
34. National Center for Biotechnology Information. Gene Expression Omnibus (GEO). http://www. ncbi.nlm.nih.gov/geo. Accessed May 2007.
35. Falcon S, Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformat- ics. 2007;23:257-258.
36. Open Biomedical Ontologies. The Gene Ontology. http://www.geneontology. org/. Accessed February 2007.
37. Eckhardt F, Lewin J, Cortese R, et al. DNA meth- ylation profiling of human chromosomes 6, 20 and 22. Nat Genet. 2006;38:1378-1385.
38. Kuppers R, Klein U, Schwering I, et al. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest. 2003;111:529-537.
39. Su AI, Wiltshire T, Batalov S, et al. A gene atlas of the mouse and human protein-encoding tran- scriptomes. Proc Natl Acad Sci USA. 2004;101: 6062-6067.
40. Antequera F, Boyes J, Bird A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell. 1990;62:503- 514.
41. Dawson DW, Hong JS, Shen RR, et al. Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas. Oncogene. 2007; 26:4243-4252.
42. Gronbaek K, Ralfkiaer U, Dahl C, et al. Frequent hypermethylation of DBC1 in malignant lympho- proliferative neoplasms. Mod Pathol. 2008;21: 632-638.
43. Li CY, Chow C, Chan WY. Allelic imbalance mapped to 6q14.1 is associated with loss of expression of 5-HT receptor 1B in non-Hodgkin lymphomas. Diagn Mol Pathol. 2004;13:69-74.
44. Younes A, Zhao S, Jendiroba D, Kleine HD, Cabanillas F, Andreeff M. Decreased expression of the deleted in colorectal carcinoma gene in non-Hodgkin's lymphoma. Blood. 1995;85:2813- 2816.
45. Francis R, Richardson C. Multipotent hematopoi- etic cells susceptible to alternative double-strand break repair pathways that promote genome rearrangements. Genes Dev. 2007;21:1064-1074.
46. Park IH, Zhao R, West JA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008;451:141-146.
47. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-872.
48. Opavsky R, Wang SH, Trikha P, et al. CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells. PLoS Genet. 2007;3:1757-1769.
49. Boyer LA, Plath K, Zeitlinger J, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature. 2006;441: 349-353.
50. Ehrich M, Turner J, Gibbs P, et al. Cytosine meth- ylation profiling of cancer cell lines. Proc Natl Acad Sci U S A. 2008;105:4844-4849.